An experimental treatment happens to be the solution to delay Alzheimer's symptoms in some people. These people are the ones who are genetically destined to get the disease in their 40s or 50s. These new findings form ongoing research has now been caught up in Trump administration funding delas. The early results of the study has been published on Wednesday and the participants too are worried that politics could cut their access to a possible lifeline.

One of the participants had said, "It is still a study but it has given me an extension to my life that I never banked on having." The participant is named Jake Henrichs, form New York City, who is 50 years old. He is one of them to be treated in that study for more than a decade now and has remained symptom-free despite inheriting an Alzheimer's-causing gene that had killed his father and brother around the same age.

Slowing Down The Symptoms

Two drugs which can modestly slow down early-stage Alzheimer's are sold in the United States. These drugs clear the brain of one of its hallmarks, a sticky gunk-like part called the amyloid. However, there have not been any hints that removing amyloid far earlier, way many years before the first symptoms appear, may postpone the disease.

How Was The Research Conducted?

The research is led by Washington University in St Louis, which involved families that passed down rare gene mutation as participants. This meant it was almost guaranteed that they will develop symptoms at the same age their affected relatives did.

The new findings is based on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight years. Long-term amyloid removal cut in half their risk of symptom onset. The study is published in the journal Lancet Neurology.

Washington University's Dr Randall Bateman, who directs the Dominantly Inherited Alzheimer's Network of studies involving families with these rare genes says, "What we want to determine over the next five years is how strong is the protection. Will they ever get the symptoms of Alzheimer’s disease if we keep treating them?”

The researchers before though did not know what exactly caused Alzheimer's which affects nearly 7 million Americans, most of them in their later life. However, it is clear that these silent changes occur in the brain at least two decades before the first symptom shows up. The big contributor. At some point amyloid buildup can trigger a protein named tau that then starts to kill neurons, which can lead to cognitive decline.

Researchers are now thus studying the Tau-fighting drugs and are looking into other factors, like inflammation, brain's immune cells and certain virus.

The National Institute of Health (NIH) has expanded its focus as researchers have found more reasons for Alzheimer's. In 2013, the NIH's National Institute on Aging funded 14 trials of possible Alzheimer's drugs over a third targeting amyloid. By last fall, there were 68 drugs and 18% of them target amyloid. However, there are scientists too who think that amyloid is not everything and their is way more in the brain tissue, immune cells, and more which can be studied.

A new experimental vaccine targeting one of pancreatic cancer's most common genetic mutations has shown encouraging results in an early-stage clinical trial.

Strong immune responses in most participants were observed, sparking fresh hope against one of the world's deadliest cancers.

About The Study

The Phase I study, published in Cancer Discovery, examined an investigational mutant KRAS-targeted vaccine (mKRAS-VAX) in patients who had undergone surgery for pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer.

The trial enrolled 12 patients with resected KRAS-mutant pancreatic cancer who received the vaccine alongside two immune checkpoint inhibitors, nivolumab and ipilimumab, after completing standard treatment.

Researchers observed vaccine-induced T-cell responses in 91.7% of patients, with immune cells remaining detectable for up to two years in some participants.

Importantly, patients who mounted stronger immune responses also appeared to remain disease-free for longer, although the study was not designed to prove that the vaccine directly improves survival.

Also read: Broadcaster Lauren Laverne Shares 'Smoldering Myeloma' Diagnosis After Cancer Recovery

Milestone Results Show Strong Immune Response

According to the researchers, pancreatic cancer has always been difficult to treat because it suppresses immune responses.

"The significant increase in vaccine-generated T-cell responses demonstrates that the immune system can be trained to recognize KRAS-mutant pancreatic cancer," the researchers said, noting that higher T-cell responses were associated with longer disease-free survival.

The researchers said that these findings support continued evaluation of KRAS-targeted vaccination strategies in larger clinical trials.

Also read: Postpartum Breast Cancer May Be Biologically More Aggressive; Here’s Why

Parallel Research Shows Potential Too

The promising study follows another recently published Phase I trial in Cancer Discovery that tested a KRAS-targeted vaccine in individuals at high risk of developing pancreatic cancer.

That study found the vaccine safely stimulated KRAS-specific T-cell responses in about 90% of participants, suggesting such vaccines may eventually help prevent pancreatic cancer in selected high-risk groups.

Dr. Neeha Zaidi, associate professor of oncology at Johns Hopkins University and one of the corresponding authors of the prevention study, said, "Individuals at high risk due to hereditary predisposition or to the presence of a concerning pancreatic lesion detected on imaging usually undergo surveillance to monitor for changes over time."

Also read: Cancer Is Not A Death Sentence Anymore: How Early Detection & Modern Treatment Are Changing Outcomes In Tier-2 Cities

She noted that surgery remains the standard treatment when cancer or high-risk lesions are detected, but recurrence remains common, highlighting the need for preventive strategies.

Elizabeth Jaffee, another author, said, "The goal of this study was to test the safety of the vaccine and induction of durable immune responses."

She added that the clinical trial was built on existing evidence showing KRAS-targeted vaccination could prevent progression of early precancerous lesions in animal .

Importance Of KRAS

KRAS is one of the most frequently mutated cancer-driving genes in pancreatic cancer, with mutations present in roughly 90% of pancreatic ductal adenocarcinomas. These mutations continuously prompt cancer cells to grow and divide.

However, scientists have spent decades trying to develop therapies capable of effectively targeting the protein.

Rather than attacking the cancer directly, the new vaccine teaches the immune system to recognize mutated KRAS proteins as abnormal and launch T-cell attacks against cancer cells.

Pancreatic cancer remains one of the most aggressive cancers worldwide because symptoms often appear only after the disease has spread beyond the pancreas.

While experts caution that the current findings come from an early-stage study, they say the results provide promising evidence that cancer vaccines can successfully activate the immune system against pancreatic tumors.

The Ludhiana health department has increased surveillance and prevention efforts after a bunch of new cases of malaria and dengue were reported in the district.

Health officials have stepped up inspections, awareness campaigns, and anti-larval operations, urging residents to eliminate stagnant water and seek medical attention at the first sign of fever.

Increase In Dengue And Malaria Breeding Sites

Also read: Monsoon Playbook for Parents: Common Home Mistakes That Increase Infection Risk in Children

According to recent reports, extensive door-to-door inspections are being carried out across residential areas, schools, and public spaces to identify mosquito breeding sites.

During these inspections, dengue mosquito larvae were found in several homes, prompting authorities to issue notices to property owners and instruct them to immediately remove stagnant water.

The department said these inspections are part of an ongoing strategy to reduce mosquito breeding before cases increase further during peak monsoon season.

Proactive Strategy To Prevent Increase In Infections

Also read: From Heavy Floods To Extremely Humid, How Mumbai's Extreme Weather Can Impact Your Health?

The move comes after Ludhiana experienced a difficult mosquito-borne disease season last year. Official data showed the district recorded 128 malaria cases, including one death, and 538 dengue cases with one fatality, making early intervention a priority this year.

Health authorities say that increasing temperatures combined with intermittent rainfall have created favourable conditions for mosquitoes to multiply rapidly, making community participation essential in preventing another surge.

Officials are stressing that dengue and malaria are transmitted by different mosquitoes and require slightly different prevention strategies.

Dengue is spread by the Aedes mosquito, which breeds in clean, stagnant water found in coolers, flower pots, buckets, discarded tyres, and rooftop water tanks. These mosquitoes are most active during the daytime.

Malaria, on the other hand, is transmitted by Anopheles mosquitoes, which usually bite from dusk until dawn.

Eliminating breeding sites remains the most effective way to reduce the spread of both diseases.

How To Protect Yourself In Monsoon?

Doctors advise residents to watch for symptoms such as high fever, severe headache, body aches, joint pain, chills, nausea, vomiting, excessive fatigue, or skin rashes. Anyone experiencing persistent fever should avoid self-medication and seek medical care promptly.

Early diagnosis helps prevent complications, particularly in severe dengue cases where warning signs such as abdominal pain, persistent vomiting, bleeding gums, or difficulty breathing require immediate hospitalization.

Health experts recommend practising a combination of personal protection and environmental control:

• Empty and scrub water coolers, flower pots, buckets, bird baths, and other water containers at least once every week.
• Keep overhead tanks, drums, and storage containers tightly covered.
• Remove discarded tyres, plastic containers, coconut shells, and other objects that can collect rainwater.
• Wear full-sleeved clothing, especially during peak mosquito activity.
• Use mosquito repellents, coils, vaporizers, or insecticide-treated bed nets where appropriate.
• Install window and door screens to reduce mosquito entry.
• Cooperate with municipal fogging and anti-larval spraying teams when they visit your locality.

Public health officials say that preventing mosquito breeding at the household level remains the strongest defence against dengue and malaria. While health officials and their teams continue surveillance for containment, they emphasize that success depends on active community participation in keeping homes and neighbourhoods free of stagnant water.

The transport of Ebola victims' bodies across provinces in the Democratic Republic of Congo (DRC) is emerging as one of the major causes of the country's rapidly expanding Ebola outbreak. The United Nations' International Organization for Migration recently issued a warning regarding the same.

According to the IOM, the movement of deceased Ebola patients from the place of death to their home communities for traditional funeral ceremonies is increasing the risk of spreading the deadly virus into previously unaffected areas. The warning comes as eastern Congo battles its largest Ebola outbreak in years, caused by the Bundibugyo strain, for which there is currently no vaccine.

Why Transporting Bodies Of Ebola Victims So Dangerous?

As of July 14, more than 2,000 Ebola cases and over 700 deaths had been reported in Congo and neighboring Uganda.

Unlike other infectious diseases, Ebola remains highly contagious even after a patient has died. The virus can be transmitted through direct contact with bodily fluids during funeral rituals, including washing, dressing, or touching the body.

In many parts of the country, families prefer to bury loved ones in their ancestral villages, often transporting bodies over long distances, which can unintentionally increase Ebola transmission.

The IOM stated that nearly two-thirds of Ebola-related deaths have occurred outside hospitals, making it difficult for trained burial teams to manage bodies safely before they are handed over to families.

Also read: WHO Says “Fastest Growing” DRC Ebola Outbreak May Be Four Times Bigger Than Official Count As Cases Near 2,000

"If we don't really manage the dead bodies well, if we don't engage the community. Then it means there will be more spread within the community," said Andrew Mbala from IOM.

According to Reuters, the agency said that at least 105 instances where bodies were transported between districts, including one case that was linked to new Ebola infections in Congo's Tshopo province.

The IOM said the current outbreak has grown by nearly 70% within two weeks, with more than 40 new cases being reported daily, highlighting how quickly the virus is spreading.

The agency stressed that safe and dignified burial practices, developed in partnership with local communities, remain one of the most effective tools for interrupting Ebola transmission.

"Ebola remains highly infectious after death, making funeral practices a critical component of outbreak control," the IOM said in its latest update.

Community Mistrust Is Another Hurdle

Health officials say the outbreak response continues to face significant obstacles beyond the virus itself.

Community resistance, misinformation, mistrust, insecurity, and attacks on healthcare workers have hampered contact tracing, safe burials, and treatment efforts.

According to the IOM, around one in five people identified as contacts of Ebola patients cannot currently be traced, making it increasingly difficult to contain transmission chains.

The outbreak, first officially recognized in May, has already spread across multiple provinces in eastern Congo.

Public health experts fear that continued movement of infected bodies, combined with undetected community transmission, could allow Ebola to reach additional regions if containment measures are not strengthened.